(Q38442184)

English

CYP2C19*2 polymorphism is associated with increased survival in breast cancer patients using tamoxifen.

scientific article published on October 2010

Statements

CYP2C19*2 polymorphism is associated with increased survival in breast cancer patients using tamoxifen. (English)
Rikje Ruiter
Monique J Bijl
Ron H N van Schaik
Els M J J Berns
Jan-Willem W Coebergh
Charlotte van Noord
Loes E Visser
Bruno H Ch Stricker
1 October 2010
1367-1375

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit